Showing 2,901 - 2,920 results of 3,189 for search '"vaccination"', query time: 0.06s Refine Results
  1. 2901

    Prevalence of Hepatitis B Viral Infection in Pregnant Women at the Suhum Municipality, Ghana by Joseph Boachie, Doreen Pidah, Henrietta Eshun, Emmanuel Jingbeja, Praise Fosu Adjei, Patrick Adu

    Published 2024-01-01
    “…Sociodemographics including history of HBV screening and vaccinations were obtained from consented individuals using pretested questionnaires. …”
    Get full text
    Article
  2. 2902

    Harnessing marine bacteria for next-gen antibiotics: potent inhibition of S. aureus and Riemerella anatipestifer through in vitro, omics, and chemoinformatics approach with enhance... by Syed Shams ul Hassan, Huizi Jin

    Published 2025-01-01
    “…To investigate the anti-bacterial mechanism, all compounds were docked with two enzymes and TLR4 protein for predicting the vaccine construct, and the best docking score was achieved against RMFP with the highest score of -12.9 for compound 4. …”
    Get full text
    Article
  3. 2903

    Social Media Recruitment as a Potential Trigger for Vulnerability: Multistakeholder Interview Study by Nina Matthes, Theresa Willem, Alena Buyx, Bettina M Zimmermann

    Published 2024-12-01
    “…MethodsAs part of an international consortium that tests a therapeutic vaccine against hepatitis B (TherVacB), we conducted 30 qualitative interviews with multidisciplinary experts in social media recruitment (from the fields of clinical research, public relations, psychology, ethics, philosophy, law, and social sciences) about the ethical, legal, and social challenges of social media recruitment. …”
    Get full text
    Article
  4. 2904

    A multivalent binding model infers antibody Fc species from systems serology. by Armaan A Abraham, Zhixin Cyrillus Tan, Priyanka Shrestha, Emily R Bozich, Aaron S Meyer

    Published 2024-12-01
    “…Using this capability, we find that COVID-19 vaccine efficacy is associated with the induction of afucosylated spike protein-targeting IgG. …”
    Get full text
    Article
  5. 2905

    Analysis of Age Appropriate Measles Immunisation among the Eligible Children in India: A Cross-Sectional Analysis of National Family Health Survey–5 by Avijit Debnath, Niranjan Roy, Dipankar Roy, Munmi Sarma, Dipanjan Roy, Kinnor Das, Deepmala Deb

    Published 2025-01-01
    “…Moreover, a considerable number of children did not even receive their first dose of the measles vaccine, and those who did generally did not receive it at the recommended age. …”
    Get full text
    Article
  6. 2906

    Evidence that a STAT3 Mutation Causing Hyper IgE Syndrome Leads to Repression of Transcriptional Activity by Sameer Bahal, Maha E. Houssen, Ania Manson, Lorena Lorenzo, Mark A. Russell, Noel G. Morgan, Fariba Tahami, Sofia Grigoriadou

    Published 2019-01-01
    “…There was suboptimal response to test immunisation with Pneumovax II vaccine. Th17 cell phenotyping revealed low levels of IL-17 expressing cells (0.3% of total CD4 T Cells numbers). …”
    Get full text
    Article
  7. 2907

    Seroprevalence Study of Dengue at a Tertiary Care Hospital in Jaipur, Rajasthan by Ashina Singla, Afreen Ali, Himanshi Galav, Ved Prakash Mamoria

    Published 2024-05-01
    “…In the absence of specific treatments and vaccines for dengue fever (DF), vector control is the only method by which the spread of dengue can be prevented. …”
    Get full text
    Article
  8. 2908
  9. 2909
  10. 2910
  11. 2911

    4-Aminoquinoline as a privileged scaffold for the design of leishmanicidal agents: structure–property relationships and key biological targets by Angel H. Romero, Francisco Delgado

    Published 2025-01-01
    “…At the moment, there are neither approved vaccines nor effective drugs for the treatment of human leishmaniasis for any of its three typical clinical manifestations, and, importantly, the drugs of clinical use have several side effects, require complex administration regimens, present high cost, and are ineffective in many populations due to pathogen resistance. …”
    Get full text
    Article
  12. 2912

    Changes in the Profile of Antibiotic Prescriptions by Dentists in Brazil during the Pandemic by Fernando de Sá Del Fiol, Isaltino Pereira de Andrade-Jr, Marcus Tolentino da Silva, Silvio Barberato-Filho, Luciane Cruz Lopes, Cristiane de Cassia Bergamaschi

    Published 2022-01-01
    “…During the COVID-19 pandemic, people worldwide, including the scientific community, were insecure and fearful. The lack of vaccines at the beginning of the pandemic and the high mortality rate led to a search for alternative treatments for COVID-19. …”
    Get full text
    Article
  13. 2913

    Evaluation of the Acute Flaccid Paralysis Virological Surveillance System in Polio-Free Morocco, 2010–2018 by Sanae Lemrabet, Maria El Qazoui, Lalla Meryem Idrissi Azzouzi, Ahmed Rguig, Malika Elhamdaoui, Abdelkarim Filali-Maltouf, Leila Medraoui, Hicham Oumzil

    Published 2022-01-01
    “…Among the 884 AFP cases identified and analyzed, we identified 11 polioviruses as Sabin-like vaccine strains (PSL). PSL were isolated in 11 samples of AFP cases received at the laboratory, including one PSL1, three PSL2 + PSL3, one PSL1 + PSL2, and one PSL1 + 2 + 3. …”
    Get full text
    Article
  14. 2914

    The First Record of an Aggressive Form of Ocular Tumour Enhanced by Marek’s Disease Virus Infection in Layer Flock in Al-Najaf, Iraq by Aoula Al-Zebeeby, Ali Hadi Abbas, Haider Abas Alsaegh, Furkan Sabbar Alaraji

    Published 2024-01-01
    “…We investigated a rapidly developed tumour mass that was observed in an MD-vaccinated layer flock that showed obvious clinical signs of MD, accompanied by forming a small lump in one eye at age 21 weeks, which developed to a big lump at week 28 of age, leading to death. …”
    Get full text
    Article
  15. 2915

    PMMB COVID-19 Bulletin: Spain (18th April 2020) by Hooi-Leng Ser, Vengadesh Letchumanan, Jodi Woan-Fei Law, Loh Teng-Hern Tan, Nurul-Syakima Ab Mutalib, Learn-Han Lee

    Published 2020-04-01
    “…The Spanish government has taken counter-measures for the management of COVID-19, consisting of the announcement of “state-of-emergency” and subsequent extension to control movements, setting up research grants to expedite drug and vaccine development in addition to introduction of the use of artificial intelligence as an official channel to provide advice and enquires about COVID-19. …”
    Get full text
    Article
  16. 2916

    Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy by Weijian Zhu, Qiang Yi, Zheng Chen, Jiaqi Wang, Kui Zhong, Xinting Ouyang, Kuan Yang, Bowei Jiang, Jianing Zhong, Jinghua Zhong

    Published 2025-02-01
    “…MAGEA4-based TCR-T cell therapy and cancer vaccines show clinical potential. This article comprehensively reviews the structure and function of MAGEA4, as well as recent research progress in solid tumors, providing a theoretical foundation for the clinical translation of MAGEA4 and its application in immunotherapy.…”
    Get full text
    Article
  17. 2917

    Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population by Catherine Apio, Md. Kamruzzaman, Taesung Park

    Published 2020-09-01
    “…No specific therapeutic agents or vaccines for COVID-19 are available, though several antiviral drugs, are under investigation as treatment agents for COVID-19. …”
    Get full text
    Article
  18. 2918

    Pityriasis lichenoides chronica following SARS-CoV-2 infection: A case report and brief report of the literature by Yusuf Can Edek, Fatma Sena Gürevin, Nilsel İlter

    Published 2024-12-01
    “…Extrinsic antigens such as drugs, infections, and vaccines can trigger the immune system and cause disease development. …”
    Get full text
    Article
  19. 2919

    Investigation of TORCH seroprevalence in a tertiary university hospital by Samet Kirat

    Published 2024-04-01
    “…The frequency of previous infections and proportion of vaccinated individuals increased in pregnant women aged 35-50 years. …”
    Get full text
    Article
  20. 2920